Breaking news

Shocking Discovery: Microplastics in Our Brains – Is This Linked to Dementia?

Every day, we unknowingly ingest and inhale microscopic plastic particles, called microplastics. These tiny fragments, less than five millimeters in size, are found everywhere – from our food to the air we breathe. While their full impact on human health is still unclear, the presence of microplastics in vital organs like the liver, kidneys, and, now, the brain, raises serious concerns.

Microplastics: What Are They?

Microplastics come in two main forms: primary and secondary. Primary microplastics are intentionally manufactured for products like cosmetics, detergents, and paints. These account for around 30% of the microplastics in the environment. Secondary microplastics, making up about 70%, form when larger plastic objects break down, such as bottles, bags, and straws. Over time, these fragments enter our bodies through ingestion and inhalation.

The Groundbreaking Study

A recent study, published in Nature Medicine, has drawn a startling connection between microplastics and dementia. Conducted by researchers at the University of New Mexico, the study analyzed post-mortem brain samples from 52 people – 28 from 2016 and 24 from 2024. Their findings were striking: microplastic levels in the brain had increased by 50% over the past eight years.

Even more concerning, microplastic levels in the brain were higher than in other organs, such as the liver and kidneys. Researchers found that among the 12 individuals diagnosed with dementia, microplastic concentrations were notably higher than in those without the condition.

Could Microplastics Cause Dementia?

While the research is still in its early stages, the possibility that microplastics may contribute to cognitive decline is unsettling. Experts like Dr. Popi Kanari, a leading chemist, caution that we need more specialized studies to confirm whether the presence of these particles in the brain is linked to diseases like dementia. However, given that microplastics are foreign substances in our bodies, their accumulation in the brain raises significant health questions.

Microplastics In Our Food And Water

This alarming trend isn’t limited to the brain. Microplastics have been detected in food, drinks, and even the air. A 2024 study revealed that 90% of animal and plant protein samples tested positive for microplastics. A separate study found that every 100 grams of rice consumed contains 3 to 4 milligrams of microplastics. Even Himalayan salt, once thought to be pure, is contaminated with microplastic particles.

The Global Response

The growing body of evidence has sparked international concern. The European Commission, in response to mounting scientific findings, has taken action to limit the use of microplastics. In 2023, they banned 78 types of microplastics and pushed for more stringent regulations. Efforts are also underway to reduce industrial microplastic use, which currently amounts to 145,000 tons annually. Yet, despite these measures, 42,000 tons still find their way into the environment each year.

Conclusion: A Looming Crisis

As research continues, the link between microplastics and health risks like dementia becomes harder to ignore. The urgent question remains: What can be done to prevent these tiny particles from entering our bodies in the first place? Until more definitive answers come, one thing is clear – microplastics are becoming an inescapable part of our lives, and their long-term impact on our health is a mystery we cannot afford to ignore.

Bank of Cyprus Upgrade Signals Fresh Optimism For Greek And Cypriot Banks

Regional Banks Enter A More Favorable Cycle

Bank of Cyprus and Eurobank are well positioned to benefit from a renewed re-rating of Greek and Cypriot bank stocks, according to Cyprus-based investment firm Roemer Capital, which upgraded Bank of Cyprus to a buy rating and reaffirmed its positive view on Eurobank.

The firm cited easing geopolitical tensions, resilient economic growth in Greece and Cyprus, lower funding costs and Greece’s expected transition to developed-market status as the main factors supporting the sector.

Roemer Capital also lowered its cost of equity assumptions, updated its forecasts following first-quarter 2026 results and extended its valuation horizon to the end of 2027, raising target prices across its banking coverage.

Bank Of Cyprus Gets The Largest Upgrade

Bank of Cyprus received the biggest revision, with Roemer Capital upgrading the stock from hold to buy and setting a target price of €11.10, implying potential total upside of 27%.

The firm highlighted the bank’s strong capital generation, profitability and projected 100% dividend payout, describing it as the strongest capital-return story among the banks under coverage. Roemer Capital maintained its buy rating on Eurobank, assigning a target price of €4.90 and forecasting potential upside of 28%. The report said the bank is well placed to benefit from loan growth, improving operating performance and merger-and-acquisition synergies.

National Bank of Greece and Piraeus Bank also retained buy ratings, with expected returns ranging from 25% to 36%. Optima Bank was upgraded to buy, while Alpha Bank remained at hold on valuation grounds.

Why Growth Still Sets The Region Apart

According to Roemer Capital, Greek and Cypriot banks continue to benefit from stronger economic fundamentals than many western European peers. The report pointed to faster economic growth, healthier balance sheets, low levels of non-performing exposures, capital ratios approaching 20% and strong customer deposit bases.

Analysts expect performing loans across the sector to grow at a compound annual rate of 6% to 8% through 2028, supported by private investment, digitalisation, green manufacturing, supply-chain expansion and a gradual recovery in household lending.

The report also said the conclusion of lending under the EU Recovery and Resilience Facility is unlikely to materially affect credit growth, as banks have already shifted back towards traditional commercial lending. Roemer Capital expects Euribor to remain between 2.2% and 2.5%, a level it believes should support both lending activity and net interest margins.

Geopolitics, Valuation And Market Structure Support The Case

The report said improving geopolitical conditions have strengthened the investment outlook, noting that Brent crude prices have largely returned to pre-war levels while Greek government bond yields have stabilised at around 3.5%. Although geopolitical risks remain, Roemer Capital believes the likelihood of a major inflationary shock or significant pressure on bank profitability has eased.

Another important catalyst identified by the firm is Greece’s expected promotion to developed-market status by FTSE Russell, STOXX and MSCI over the coming months.

According to the report, the reclassification should improve liquidity and attract a broader base of international investors. Roemer Capital also said Euronext’s acquisition of the Athens Exchange is expected to strengthen market infrastructure and increase international visibility, particularly for Bank of Cyprus and Optima Bank.

The firm noted that Bank of Cyprus has already benefited from its Athens listing, with average daily trading value increasing from less than €400,000 before its September 2024 move to nearly €6 million afterwards.

Economic Momentum Remains A Core Tailwind

Roemer Capital said both Greece and Cyprus have moved beyond post-crisis recovery and are now supported by private-sector-led growth. For Cyprus, the report highlighted recent tax reform and efforts to simplify the legal and regulatory framework, while also noting that limited foreign banking competition continues to support domestic lenders.

Overall, Roemer Capital expects Greek and Cypriot banks to remain well-positioned for profitable loan growth over the coming years.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter